Nuvectis Pharma Q3 EPS $(1.02) Misses $(0.24) Estimate
Benzinga Newsdesk 6 days ago
NewsEarningsEarnings Misses
Nuvectis Pharma (NASDAQ:NVCT) reported quarterly losses of $(1.02) per share which missed the analyst consensus estimate of $(0.24) by 325 percent. This is a 131.82 percent decrease over losses of $(0.44) per share from
Nuvectis Pharma (NASDAQ:NVCT) reported quarterly losses of $(1.02) per share which missed the analyst consensus estimate of $(0.24) by 325 percent. This is a 131.82 percent decrease over losses of $(0.44) per share from the same period last year.